6-3273111-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015482.2(SLC22A23):āc.2005G>Cā(p.Ala669Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000937 in 1,601,176 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015482.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC22A23 | NM_015482.2 | c.2005G>C | p.Ala669Pro | missense_variant | 10/10 | ENST00000406686.8 | NP_056297.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC22A23 | ENST00000406686.8 | c.2005G>C | p.Ala669Pro | missense_variant | 10/10 | 5 | NM_015482.2 | ENSP00000385028 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152252Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000617 AC: 15AN: 243186Hom.: 0 AF XY: 0.0000227 AC XY: 3AN XY: 132242
GnomAD4 exome AF: 0.00000966 AC: 14AN: 1448924Hom.: 0 Cov.: 31 AF XY: 0.00000278 AC XY: 2AN XY: 720078
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152252Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2023 | The c.2005G>C (p.A669P) alteration is located in exon 10 (coding exon 10) of the SLC22A23 gene. This alteration results from a G to C substitution at nucleotide position 2005, causing the alanine (A) at amino acid position 669 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at